James T. Huie

James T. Huie

Partner

Experienced Advisor in Life Sciences and Tech

James has extensive experience representing venture capital firms and other investors in private equity and debt financings.
A Recognized Practitioner

James was named to the 2014 and 2015 editions of the "Rising Stars" list published by Northern California Super Lawyers.

James Huie is a corporate and securities partner in Wilson Sonsini Goodrich & Rosati's San Francisco office, where he has one of the most active practices in the country representing venture-backed companies. He advises life sciences and technology companies on general corporate matters, mergers and acquisitions, initial public offerings, strategic partnerships, and private equity and debt financings. He also has extensive experience in representing venture capital firms and other investors in private equity and debt financings.

James also serves on the investment committee for the firm's affiliated fund, the WS Investment Company.

Experience

James also serves on the investment committee for the firm's affiliated fund, the WS Investment Company.

Education

J.D., Santa Clara University School of Law, 2005Senior Comments Editor, Santa Clara Computer & High Technology Law Journal
B.A., Molecular Cell Biology, University of California, Berkeley, 2002With Distinction, Emphasis in Biochemistry

Admissions

State Bar of California

Credentials

Education

J.D., Santa Clara University School of Law, 2005Senior Comments Editor, Santa Clara Computer & High Technology Law Journal
B.A., Molecular Cell Biology, University of California, Berkeley, 2002With Distinction, Emphasis in Biochemistry

Admissions

State Bar of California

Select Publications

Co-author with J. Milner, “FoodTech White Paper: 2020 Trends in Venture Capital Financings,” March 2021

Insights

Select Publications

Co-author with J. Milner, “FoodTech White Paper: 2020 Trends in Venture Capital Financings,” March 2021

Recent Insights

Client Highlights

On August 15, 2024, Neptune Medical, a leader in medical device innovation, announced the completion of a $97 million Series D financing. Sonder Capital and Olympus Corporation of the Americas were significant participants in the round, which included investments from other existing and new investors. Wilson Sonsini Goodrich & Rosati advised Neptune Medical on the transaction.

The financing will strengthen Neptune Medical as a gastrointestinal-focused company expanding into robotics for GI disease, as evidenced by the recent appointment of medical robotics pioneer Dr. Fred Moll as chairman of the company’s board.

Neptune Medical also announced the successful spinout of its subsidiary, Jupiter Endovascular, which is developing a new class of endovascular procedures to bring the precision and control of direct surgical access to catheter-based interventions. Wilson Sonsini will represent Jupiter Endovascular moving forward.

The Wilson Sonsini team that advised Neptune Medical on the Series D financing included James Huie, Brian Appel, MJ Han, and Ryan Isola.

For more information, please see Neptune Medical’s news release. Additional coverage is available in Fierce Biotech.

Learn More

Client Highlights

On July 10, 2024, Adona Medical, a Shifamed portfolio company that aims to deliver advanced solutions for heart failure, announced that it has secured $33.5 million in Series C financing. The financing was led by Cormorant Asset Management and TCP Health Ventures, with participation from Excelestar Ventures, the PA MedTech VC Fund II, Unorthodox Ventures, AMED Ventures, and other new and existing investors. Wilson Sonsini Goodrich & Rosati advised Adona Medical on the transaction.

Learn More

View All

Recent Events

WSGR Events

Wilson Sonsini Goodrich & Rosati’s 31st Annual Medical Device & Digital Health Conference will address topics of critical importance to medical device and digital health companies today, including key healthcare regulatory considerations, the relationship between intellectual property and valuation, a look back at 2023’s fundraising and deals, and how 2024 is shaping up along with partnering strategies in the current market.

Learn More

Affiliated Programs

Join us at this exclusive networking event hosted by the UCSF Rosenman Institute and sponsored by Wilson Sonsini. "Entrepreneurial Spirits" offers a relaxed setting for engaging directly with leading investors and innovators in the healthcare community.

Learn More